Good evening :)
Expleo Solutions Ltd

Expleo Solutions Ltd

EXPLEOSOL Share Price

NSE
₹801.551.54% (-12.55)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Information Technology
Software ServicesCybersecurity
Smallcap

With a market cap of ₹1,243 cr, stock is ranked 1,452

Moderate Risk

Stock is 2.68x as volatile as Nifty

EXPLEOSOL Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

Avg

Can be considered moderately valued vs the market

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Information Technology
Software ServicesCybersecurity
Smallcap

With a market cap of ₹1,243 cr, stock is ranked 1,452

Moderate Risk

Stock is 2.68x as volatile as Nifty

EXPLEOSOL Performance & Key Metrics

EXPLEOSOL Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
10.031.96—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
21.385.553.30%

EXPLEOSOL Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
0%
Analysts have suggested that investors can buy this stock

from 1 analyst

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

EXPLEOSOL Company Profile

Expleo Solutions is an India-based holding company. The Company is engaged in providing software testing services.

Investor Presentation

View older View older 

May 13, 2026

PDF
View Older Presentations

EXPLEOSOL Similar Stocks (Peers)

Compare with peers Compare with peers 

EXPLEOSOL Similar Stocks (Peers)

Compare with peers Compare with peers 
Oracle Financial Services Software Ltd
OFSS
PE Ratio
35.14
35.14
1Y Return
19.16%
19.16%
Buy Reco %
100.00
100.00
Persistent Systems Ltd
PERSISTENT
PE Ratio
43.69
43.69
1Y Return
0.51%
0.51%
Buy Reco %
61.29
61.29
L&T Technology Services Ltd
LTTS
PE Ratio
28.34
28.34
1Y Return
20.51%
20.51%
Buy Reco %
40.74
40.74
Tata Elxsi Ltd
TATAELXSI
PE Ratio
35.07
35.07
1Y Return
43.17%
43.17%
Buy Reco %
41.67
41.67
Pine Labs Ltd
PINELABS
PE Ratio
149.39
149.39
1Y Return
41.94%
41.94%
Buy Reco %
87.50
87.50
Compare with Peers

EXPLEOSOL Sentiment Analysis

EXPLEOSOL Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

EXPLEOSOL Stock Summary · May 2026

Headline: Results showed currency‑helped top‑line growth but margin compression and strategic reinvestment, with management stressing AI adoption and disciplined cost control. Q4 total income was INR 2,989 million, up 14.8% year‑on‑year, and management guided FY27 operating EBITDA margin around the mid‑teens (about 15–16%). Management described a constructive but cautious tone, highlighting that rupee depreciation materially boosted revenue and mark‑to‑market other income while constant‑currency trends were modestly negative, and they emphasized embedding AI across client engagements even if it cannibalizes near‑term revenue to preserve long‑term relationships. They cited wage inflation and one‑time labor‑related costs as drivers of adjusted EBITDA margin compression and stressed operating‑expense discipline and reduced discretionary spend to protect margins. Commercially, they are shifting go‑to‑market toward new‑logo acquisition, expanding partner‑led initiatives, pursuing a targeted M&A pipeline with likely near‑term deal closure, and prioritizing regional market building in Egypt and capacity expansion in aerospace & defense. Near term, they reiterated the mid‑teens EBITDA margin target and warned guidance is sensitive to currency movements.

EXPLEOSOL Stock Growth Drivers
EXPLEOSOL Stock Growth Drivers
7
  • Strong recent financial performance and improved liquidity with disciplined capital allocation

    The company delivered a materially stronger Q4 FY'26 and FY'26 performance, with Q4 total income

  • Early‑mover AI strategy and capability build‑out

    The company has moved from pilot to platform, deploying the expleo.ai platform last year and

EXPLEOSOL Stock Challenges
EXPLEOSOL Stock Challenges
11
  • AI-driven revenue compression and cannibalization of legacy work

    AI adoption is already materially compressing deal economics: management reports that similar pieces of work

  • Limited ability to monetize AI productivity gains due to customer pricing pressure

    Market dynamics force most AI-driven savings to be passed back to clients, constraining the company's

EXPLEOSOL Forecast

EXPLEOSOL Forecasts

Price

Revenue

Earnings

EXPLEOSOL Share Price Forecast

EXPLEOSOL Share Price Forecast

2026
Current
₹801.55
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2026
Current
₹801.55
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—

All values in ₹

EXPLEOSOL Company Revenue Forecast

EXPLEOSOL Company Revenue Forecast

2026
Current
₹1.15
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

Loading...
2026
Current
₹1.15
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹ Thousand cr.

EXPLEOSOL Stock EPS (Earnings Per Share) Forecast

EXPLEOSOL Stock EPS (Earnings Per Share) Forecast

2026
Current
₹79.89
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

Loading...
2026
Current
₹79.89
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—

All values in ₹

EXPLEOSOL

EXPLEOSOL

Income

Balance Sheet

Cash Flow

EXPLEOSOL Income Statement

EXPLEOSOL Income Statement

Loading...

Quarterdec 2023mar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026
Total Revenue261.51257.22254.36271.94260.44260.31266.59295.40289.74300.91
Operating & Other expensessubtract211.76221.19213.37216.98219.04215.79229.92235.99250.07243.54
Depreciation/Amortizationsubtract8.449.099.369.5212.378.057.677.447.305.92
Interest & Other Itemssubtract0.630.760.680.970.730.940.640.600.420.57
Taxes & Other Itemssubtract6.6410.497.058.988.5111.447.9311.639.829.21
EPS21.9310.1215.4022.8612.7515.5113.1625.6214.2626.85
See Costs

EPS in ₹. Other numbers in ₹ cr

EXPLEOSOL Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual Report Pending

Investor Presentation

May 13PDF
Feb 3PDF
Nov 13PDF
Aug 14PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 22PDF
Feb 6PDF
Nov 14PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 10PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 26PDF
Feb 14PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
 

EXPLEOSOL Stock Peers

EXPLEOSOL Past Performance & Peer Comparison

EXPLEOSOL Past Performance & Peer Comparison

Comparing 3 stocks from 
Information TechnologySoftware Services

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Expleo Solutions Ltd10.031.96—
Oracle Financial Services Software Ltd35.1411.853.75%
Persistent Systems Ltd43.6910.400.77%
L&T Technology Services Ltd28.345.581.69%

EXPLEOSOL Stock Price Comparison

Compare EXPLEOSOL with any stock or ETF
Compare EXPLEOSOL with any stock or ETF
EXPLEOSOL
Loading...

EXPLEOSOL Holdings

EXPLEOSOL Shareholdings

EXPLEOSOL Promoter Holdings Trend

EXPLEOSOL Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

EXPLEOSOL Institutional Holdings Trend

EXPLEOSOL Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

EXPLEOSOL Shareholding Pattern

EXPLEOSOL Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding71.05%0.00%0.12%0.13%28.70%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

EXPLEOSOL Shareholding History

EXPLEOSOL Shareholding History

MarJunSepDec '25MarJun0.33%0.10%0.13%0.32%0.42%0.13%

EXPLEOSOL Insider Trades & Bulk Stock Deals

EXPLEOSOL Insider Trades & Bulk Stock Deals

Loading...

smallcases containing EXPLEOSOL stock

smallcases containing EXPLEOSOL stock

Looks like this stock is not in any smallcase yet.

EXPLEOSOL Events

EXPLEOSOL Events

EXPLEOSOL Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

EXPLEOSOL Dividend Trend

No dividend trend available

EXPLEOSOL Upcoming Dividends

EXPLEOSOL Upcoming Dividends

No upcoming dividends are available

EXPLEOSOL Past Dividends

EXPLEOSOL Past Dividends

Cash Dividend

Ex DateEx DateFeb 12, 2025

Interim
Interim | Div/Share: ₹50.00

Dividend/Share

₹50.00

Ex DateEx Date

Feb 12, 2025

Cash Dividend

Ex DateEx DateJul 14, 2023

Final
Final | Div/Share: ₹5.00

Dividend/Share

₹5.00

Ex DateEx Date

Jul 14, 2023

Cash Dividend

Ex DateEx DateJul 19, 2018

Final
Final | Div/Share: ₹20.00

Dividend/Share

₹20.00

Ex DateEx Date

Jul 19, 2018

Cash Dividend

Ex DateEx DateNov 9, 2017

Interim
Interim | Div/Share: ₹4.00

Dividend/Share

₹4.00

Ex DateEx Date

Nov 9, 2017

Cash Dividend

Ex DateEx DateJul 20, 2017

Final
Final | Div/Share: ₹20.00

Dividend/Share

₹20.00

Ex DateEx Date

Jul 20, 2017

EXPLEOSOL Stock News & Opinions

EXPLEOSOL Stock News & Opinions

Corporate
Corporate
Expleo Solutions to consider Dividend

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 27 July 2026.

3 days agoCapital Market - Live
Corporate
Corporate
Expleo Solutions schedules AGM

Expleo Solutions announced that the Annual General Meeting(AGM) of the company will be held on 26 August 2026.

2 weeks agoCapital Market - Live
Corporate
Corporate
Expleo Solutions does not recommend Dividend

The Board of Expleo Solutions at the meeting held on 9th July 2026 has decided not to declare dividend and to conserve the resources and use them effectively for achieving growth and capture new opportunities in the market.

2 weeks agoCapital Market - Live
Corporate
Corporate
Expleo Solutions announces board meeting date

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 9 July 2026.

2 weeks agoCapital Market - Live
Corporate
Corporate
Expleo Solutions to hold board meeting

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 13 May 2026.

2 months agoCapital Market - Live
Earnings
Earnings
Expleo Solutions consolidated net profit rises 11.88% in the December 2025 quarter

Net profit of Expleo Solutions rose 11.88% to Rs 22.13 crore in the quarter ended December 2025 as against Rs 19.78 crore during the previous quarter ended December 2024. Sales rose 8.45% to Rs 279.35 crore in the quarter ended December 2025 as against Rs 257.58 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales279.35257.58 8 OPM %16.4914.96 - PBDT56.0440.67 38 PBT48.7428.30 72 NP22.1319.78 12 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Corporate
Expleo Solutions to hold board meeting

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Earnings
Expleo Solutions consolidated net profit rises 12.03% in the September 2025 quarter

Net profit of Expleo Solutions rose 12.03% to Rs 39.76 crore in the quarter ended September 2025 as against Rs 35.49 crore during the previous quarter ended September 2024. Sales rose 9.04% to Rs 282.70 crore in the quarter ended September 2025 as against Rs 259.26 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales282.70259.26 9 OPM %16.5216.31 - PBDT58.8253.99 9 PBT51.3844.47 16 NP39.7635.49 12 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Corporate
Expleo Solutions to hold board meeting

Expleo Solutions will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live

8 months agoCapital Market - Live
Earnings
Earnings
Expleo Solutions consolidated net profit declines 14.52% in the June 2025 quarter

Net profit of Expleo Solutions declined 14.52% to Rs 20.43 crore in the quarter ended June 2025 as against Rs 23.90 crore during the previous quarter ended June 2024. Sales rose 2.97% to Rs 259.65 crore in the quarter ended June 2025 as against Rs 252.17 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales259.65252.17 3 OPM %11.4515.39 - PBDT36.0340.31 -11 PBT28.3630.95 -8 NP20.4323.90 -15 Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Expleo Solutions Ltd (EXPLEOSOL) today?

    The share price of EXPLEOSOL as on 24th July 2026 is ₹801.55. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Expleo Solutions Ltd (EXPLEOSOL) share?

    The past returns of Expleo Solutions Ltd (EXPLEOSOL) share are
    • Past 1 week: 0.19%
    • Past 1 month: -2.43%
    • Past 3 months: -0.27%
    • Past 6 months: -9.83%
    • Past 1 year: -35.14%
    • Past 3 years: -50.09%
    • Past 5 years: -29.04%

  3. What are the peers or stocks similar to Expleo Solutions Ltd (EXPLEOSOL)?

    The peers or stocks similar to Expleo Solutions Ltd (EXPLEOSOL) include:

  4. What is the market cap of Expleo Solutions Ltd (EXPLEOSOL) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Expleo Solutions Ltd (EXPLEOSOL) is ₹1243.98 Cr as of 24th July 2026.

  5. What is the 52 week high and low of Expleo Solutions Ltd (EXPLEOSOL) share?

    The 52-week high of Expleo Solutions Ltd (EXPLEOSOL) is ₹1245 and the 52-week low is ₹640.

  6. What is the PE and PB ratio of Expleo Solutions Ltd (EXPLEOSOL) stock?

    The P/E (price-to-earnings) ratio of Expleo Solutions Ltd (EXPLEOSOL) is 10.03. The P/B (price-to-book) ratio is 1.96.

  7. Which sector does Expleo Solutions Ltd (EXPLEOSOL) belong to?

    Expleo Solutions Ltd (EXPLEOSOL) belongs to the Information Technology sector & Software Services sub-sector.

  8. How to buy Expleo Solutions Ltd (EXPLEOSOL) shares?

    You can directly buy Expleo Solutions Ltd (EXPLEOSOL) shares on Tickertape. Simply sign up, connect your demat account and place your order.